bovin
coronaviru
isol
eight
differ
state
usa
compar
antigen
properti
suscept
hygromycin
b
antigen
differ
observ
among
isol
oneway
hemagglutinationinhibit
hi
test
use
polyclon
antiserum
mebu
bovin
coronaviru
isol
differ
observ
isoelectr
focus
among
viral
protein
isoelectr
point
bcv
isol
suscept
hygromycin
b
mm
wherea
hygromycin
b
resist
isol
also
found
see
front
matter
elsevi
scienc
bv
right
reserv
pii
diarrhea
respiratori
diseas
clinic
import
caus
high
mortal
calv
virtala
et
al
bovin
coronaviru
bcv
econom
import
caus
intestin
respiratori
diseas
calv
also
implic
winter
dysenteri
adult
cattl
clark
despit
differ
clinic
diseas
believ
bcv
isol
belong
singl
serotyp
clark
genom
coronavirus
largest
among
rna
virus
lai
coronaviru
high
frequenc
recombin
rna
polymeras
lack
proofread
defect
interf
rna
frequent
gener
coronavirus
lai
bcv
isol
canada
divid
three
subgroup
basi
reactiv
monoclon
antibodi
mab
spike
protein
bcv
michaud
dea
veterinari
microbiolog
current
modifi
live
bcv
vaccin
clinic
effect
thurber
et
al
lack
clinic
efficaci
vaccin
may
due
antigen
differ
among
vaccin
field
isol
bcv
minor
antigen
biolog
differ
observ
among
bcv
isol
calf
diarrhea
winter
dysenteri
case
usa
tsunemitsu
saif
canada
dea
et
al
understand
molecular
epidemiolog
bcv
bcv
isol
eight
state
usa
compar
compar
antigen
differ
oneway
hemagglutinationinhibit
hi
test
isoelectr
focus
bcv
protein
rel
suscept
bcv
isol
hygromycin
b
bcv
isol
clinic
sampl
contain
coronaviruslik
particl
observ
neg
contrast
electron
microscopi
describ
kapil
et
al
briefli
human
rectal
cell
line
inocul
fecal
suspens
inocul
suspens
filter
mm
filter
gelman
scienc
ann
arbor
mi
confluent
monolay
wash
calcium
magnesium
free
phosphat
buffer
salin
contain
trypsin
mgml
ml
filter
fecal
suspens
ad
confluent
monolay
viru
allow
adsorb
hour
minimum
essenti
medium
contain
trypsin
mgml
gibco
brl
life
technolog
gaithersburg
md
pancreatin
mgml
sigma
mo
ad
monolay
examin
daili
day
cytopath
effect
success
propag
bcv
isol
cell
california
kansa
minnesota
nebraska
north
dakota
oklahoma
wisconsin
wyom
tissu
cultur
propag
bcv
isol
compar
passag
hemagglutin
test
perform
vbottom
plate
dynatech
laboratori
twofold
dilut
bcv
sampl
ml
prepar
phosphat
buffer
salin
pb
contain
bovin
serum
albumin
sigma
addit
ml
mous
erythrocyt
plate
incub
min
hemagglutin
titer
express
reciproc
highest
dilut
show
complet
agglutin
hi
test
cell
cultur
propag
bcv
isol
california
kansa
minnesota
nebraska
wisconsin
wyom
wildtyp
origin
fecal
sampl
propag
cell
cultur
bcv
isol
california
nebraska
wisconsin
wyom
compar
hi
test
wildtyp
sampl
cell
cultur
propag
bcv
isol
also
test
hi
test
prepar
antiserum
procedur
hi
test
describ
sato
et
al
remov
nonspecif
hi
ml
antibcv
antiserum
nation
veterinari
servic
laboratori
ame
ia
made
mebu
isol
dilut
ml
pb
inactiv
min
mix
ml
kaolin
fisher
scientif
fairlawn
nj
shake
h
kaolin
remov
centrifug
g
min
clear
supernat
mix
ml
pack
normal
mous
erythrocyt
remov
nonspecif
hemagglutinin
incub
h
treat
bcv
antiserum
separ
mous
erythrocyt
centrifug
hi
test
four
eight
ha
unit
bcv
isol
ml
mix
ml
treat
bcv
antiserum
incub
hour
mous
erythrocyt
suspens
ml
ad
plate
reincub
min
hi
activ
bcv
antiserum
isol
bcv
record
reciproc
highest
dilut
antiserum
show
complet
inhibit
hemagglutin
sato
et
al
viru
isol
back
titrat
perform
time
assur
four
eight
ha
unit
bcv
use
sampl
repeat
three
four
time
confirm
result
test
found
reproduc
bovin
coronaviru
purif
procedur
describ
previous
king
brian
infect
cell
harvest
approxim
show
cytopath
effect
round
detach
syncytia
format
briefli
three
freezethaw
cycl
cell
scrape
pool
cellular
debri
remov
centrifug
g
min
clear
supernat
filter
mm
filter
gelman
scienc
mi
polyethylen
glycol
ad
final
concentr
wv
overnight
incub
viru
precipit
pellet
g
min
pellet
save
resuspend
tnf
buffer
ph
bcv
purifi
sucros
gradient
sucros
solut
made
tne
pellet
layer
ww
sucros
gradient
centrifug
g
h
viru
interphas
collect
dilut
tne
layer
step
gradient
sucros
ml
centrifug
g
rpm
overnight
band
collect
centrifug
g
h
pellet
viru
store
isoelectr
focus
gel
made
acrylamideampholyt
solut
biolyt
bio
rad
ph
use
ammonium
persulf
h
phosphat
teme
catalyst
polymer
photopolymer
min
one
side
side
irradi
min
elimin
unpolymer
monom
gel
surfac
purifi
viru
treat
equal
volum
sampl
buffer
urea
triton
biolyt
ph
room
temperatur
h
appli
total
volum
ml
gel
dispos
templat
sampl
allow
diffus
gel
min
focus
done
v
min
increas
v
min
v
h
min
bcv
protein
detect
silver
stain
biorad
ief
gel
plastic
support
left
dri
overnight
clean
area
room
temperatur
assess
suscept
bcv
isol
hygromycin
b
ad
concentr
mm
cell
cultur
medium
sampl
propag
presenc
absenc
hygromycin
b
h
plate
frozen
thaw
three
time
plate
centrifug
clear
supernat
collect
amount
bcv
cultur
supernat
quantifi
hi
test
hi
test
wildtyp
bcv
sampl
show
low
reactiv
hi
titer
type
iii
three
sampl
show
high
reactiv
inhibit
hi
titer
type
one
sampl
inhibit
type
ii
fig
hi
titer
cell
cultur
propag
bcv
isol
rang
fig
sampl
compar
call
cultur
propag
bcv
isol
except
hi
titer
cell
cultur
propag
bcv
compar
higher
wildtyp
bcv
isol
similar
protein
band
could
detect
bcv
isol
studi
sdspage
analysi
data
shown
protein
band
detect
uninfect
cell
process
similar
manner
ident
bcv
protein
confirm
western
blot
analysi
radio
immunoprecipit
polyclon
antibodi
bovin
antibcv
antiserum
detect
bcv
protein
spike
dimer
spike
subunit
nucleoprotein
hemagglutininesteras
protein
dimer
subunit
membran
protein
molecular
weight
hemagglutininesteras
protein
bcv
isol
studi
basi
seven
wisconsin
bcv
isol
studi
conclud
band
invari
differ
bcv
isol
sharpli
focus
ief
gel
howev
band
toward
anod
end
ief
profil
pi
show
variat
differ
isol
even
differ
fraction
isol
doubleband
migrat
pi
bcv
isol
fraction
b
fraction
migrat
pi
fig
demonstr
differ
sampl
repeat
least
three
time
ief
protocol
standard
ensur
reproduc
differ
bcv
isol
rel
suscept
bcv
isol
hygromycin
b
studi
tabl
drop
hemagglutin
liter
higher
consid
signific
bcv
isol
consid
suscept
hygromycin
b
basi
criteria
four
bcv
isol
mn
mn
mn
mn
consid
resist
hygromycin
b
howev
bcv
isol
suscept
hygromycin
b
isol
bcv
calf
diarrhea
winter
dysenteri
differ
cytopatholog
isol
non
fusogen
other
weakli
highli
fusogen
dea
et
al
cytopath
effect
produc
bcv
isol
correl
clinic
condit
depend
presenc
trypsin
medium
dea
et
al
similarli
differ
observ
cpe
among
calf
diarrhea
winter
dysenteri
isol
anoth
group
tsunemitsu
saif
observ
differ
cytopath
effect
among
calf
diarrhea
isol
howev
passag
number
plaqu
purif
presenc
trypsin
pancreatin
cell
cultur
medium
greatli
affect
cytopatholog
bcv
isol
possibl
isol
bcv
fastidi
grow
cell
line
grow
organ
cultur
kapil
et
al
plaqu
variat
also
observ
among
bcv
isol
isol
differ
size
shape
plaqu
kapil
et
al
believ
bcv
isol
antigen
relat
clark
bcv
isol
differ
significantli
reactiv
indirect
immunofluoresc
test
tsunemitsu
saif
either
slight
differ
observ
viru
neutral
test
dea
et
al
tsunemitsu
saif
spike
protein
major
immunogen
elicit
antibodi
detect
neutral
indirect
fluoresc
antibodi
test
saif
elicit
bulk
cross
reactiv
antibodi
among
bcv
isol
spike
protein
may
use
differenti
bcv
isol
minor
antigen
variat
observ
among
bcv
isol
neonat
calf
diarrhea
winter
dysenteri
case
oneway
test
dea
et
al
result
studi
fig
hemagglutinationinhibit
activ
antibovin
coronaviru
mebu
isol
antiserum
cell
cultur
propag
bovin
coronaviru
isol
basi
one
way
hi
test
bcv
isol
inhibit
xaxi
denot
hi
titer
number
indic
superscript
log
yaxi
indic
number
bcv
isol
inhibit
support
extend
previous
report
find
hi
test
use
larg
number
american
isol
collect
eight
differ
state
usa
none
previou
studi
dea
et
al
tsunemitsu
saif
report
hi
result
wildtyp
bcv
viru
fecal
sampl
result
wildtyp
isol
may
need
cautiou
interpret
presenc
colostr
iggl
local
iga
fece
may
interfer
result
hand
passag
bcv
also
affect
hi
passag
bcv
cell
cultur
may
also
affect
antigen
composit
hussain
et
al
hemagglutin
activ
storz
et
al
intestin
replic
bcv
kapil
et
al
import
studi
isol
low
passag
passag
passag
american
studi
sampl
studi
differ
passag
tsunemitsu
saif
tri
develop
polyclon
antiserum
type
iii
bcv
isol
type
iii
antiserum
high
titer
could
studi
twoway
hi
relationship
among
bcv
isol
bcv
isol
cell
cultur
passag
viru
show
higher
hi
titer
compar
wildtyp
viru
fecal
sampl
cell
culturepropag
wildtyp
version
bcv
compar
show
hi
titer
respect
may
hyperimmun
serum
use
hi
test
produc
bcv
isol
highli
adapt
cell
cultur
could
due
presenc
antibodi
fece
may
uniqu
properti
isol
type
wildtyp
bcv
isol
hi
may
use
studi
epidemiolog
bcv
hemagglutin
receptor
destroy
activ
correl
clinic
sourc
bcv
isol
tsunemitsu
saif
number
studi
publish
american
hussain
et
al
french
vautherot
laport
canadian
michaud
dea
english
elghorr
et
al
scottish
clark
et
al
isol
bcv
antigen
compar
use
panel
mab
previou
studi
except
canadian
studi
fail
classifi
bcv
isol
subgroup
monoclon
antibodi
neutral
bcv
isol
scottish
isol
mebu
isol
pq
canadian
isol
neutral
isol
bcv
english
isol
ck
scottish
isol
howev
canadian
studi
quebec
isol
collect
classifi
three
antigen
subgroup
michaud
dea
basi
reactiv
panel
mab
observ
minor
differ
protein
profil
bcv
isol
sdspage
analysi
western
blot
analysi
radio
immunoprecipit
bcv
isol
data
shown
similarli
differ
observ
among
neonat
calf
diarrhea
winter
dysenteri
isol
quebec
western
blot
analysi
dea
et
al
howev
minor
differ
observ
isoelectr
focus
bcv
protein
fig
differ
serotyp
infecti
bronchiti
viru
sadasiv
et
al
temperatur
sensit
mutant
mous
hepat
viru
oleszak
et
al
differ
isoelectr
focus
spike
protein
isoelectr
focus
tediou
procedur
need
lot
care
standard
research
laboratori
studi
suitabl
point
applic
sampl
determin
appli
purifi
bcv
three
differ
place
cm
cathod
sampl
applic
cm
cathod
suitabl
band
wavi
applic
sampl
cm
cathod
found
suitabl
ief
analysi
fig
tri
three
differ
shape
templat
applic
bcv
protein
sampl
squar
horizont
slit
dash
vertic
slit
opinion
dash
gave
clearli
visibl
band
observ
vari
level
suscept
bcv
isol
hygromycin
b
mechan
action
hygromycin
b
known
howev
differenti
suscept
bcv
isol
point
direct
action
hygromycin
b
bcv
rna
replic
isol
bcv
found
suscept
low
concentr
hygromycin
b
mm
hygromycin
report
toxic
cattl
hygromycin
b
may
possibl
treatment
scour
caus
bcv
moreov
rel
suscept
bcv
isol
hygromycin
b
provid
easi
epidemiolog
marker
differenti
bcv
isol
suscept
resist
categori
easili
adopt
diagnost
laboratori
tri
differenti
bcv
isol
suscept
bcv
isol
hygromycin
b
adopt
veterinari
diagnost
laboratori
facil
cell
cultur
first
bcv
isol
presenc
trypsin
pancreatin
kapil
et
al
viru
propag
presenc
hygromycin
b
access
suscept
titer
viru
measur
hi
hemagglutininesteras
gene
winter
dysenteri
isol
two
neonat
calf
diarrhea
isol
quebec
canada
compar
mebu
isol
bcv
frame
shift
delet
insert
chang
observ
dea
et
al
hemagglutininesteras
cdna
highli
virul
bovin
coronaviru
avirul
bovin
coronaviru
compar
four
amino
acid
substitut
occur
zhang
et
al
similarli
observ
minor
chang
among
two
hemagglutinin
esteras
cdna
sequenc
far
zhang
kapil
unpublish
result
thu
differ
observ
hi
test
explain
level
nucleic
acid
sequenc
dea
et
al
wildtyp
bcv
isol
could
inhibit
bcv
antiserum
mebu
isol
fig
indic
presenc
antigen
differ
bcv
isol
specul
multival
vaccin
contain
differ
serotyp
type
ii
iii
bcv
select
basi
hi
pattern
might
offer
better
protect
current
monoval
modifi
live
viru
vaccin
clinic
effect
deleeuw
tiessink
techniqu
describ
paper
use
diagnost
laboratori
type
bcv
isol
easili
adopt
veterinari
diagnost
laboratori
bcv
isol
differenti
hi
suscept
resist
hygromycin
b
